Side effects
Burning or tingling skin on the Wegovy pill
It is a listed side effect. The label calls it dysesthesia: burning, tingling, sensitive or painful skin. In the 25 mg tablet trial, 5 percent of people on the pill reported it and nobody on placebo did, and the label says it becomes more frequent as the dose and blood levels rise.
The Oolite team, from the FDA labels
Sources checked Oct 27, 2026
Published Nov 13, 2026
Updated Oct 27, 2026 · 2 min read
The short answer
It is a listed side effect. The label calls it dysesthesia: burning, tingling, sensitive or painful skin. In the 25 mg tablet trial, 5 percent of people on the pill reported it and nobody on placebo did, and the label says it becomes more frequent as the dose and blood levels rise.
What the label says
The side effects section (§6.1) gives it its own paragraph, for the injection and the tablet together:
From the labelDysesthesia, and related events of altered skin sensations including paresthesia, pain of skin, sensitive skin, and burning skin sensation, occurred in clinical trials with WEGOVY® injection and tablet. The incidence of dysesthesia with WEGOVY® increased with increasing dosage and drug levels in the blood.
Then the number for the pill:
From the labelIn a clinical trial with WEGOVY® 25 mg tablets, 5% of WEGOVY®-treated patients and no placebo-treated patients reported dysesthesia adverse reactions.
The Medication Guide puts it in plain words, in its list of the most common side effects: changes in skin sensations.
Why the dose matters
The label ties the effect to how much semaglutide is in the blood, not to the form it comes in. That makes two things relevant on the pill.
The first is the schedule. The tablet goes from 1.5 mg to 4 mg, then 9 mg, then 25 mg, and the 5 percent figure comes from people at 25 mg. A sensation that appears after a step up fits the pattern the label describes.
The second is the spread. The pharmacology section (§12.3) says blood levels vary more from person to person with the tablet than with the 2.4 mg shot: in 90 percent of people, average levels fell between 27 and 186 nmol/L on the 25 mg tablet, against 51 and 110 nmol/L on the injection. Two people on the same tablet can sit at quite different levels.
What happened next, in the trials
The label's detail on the course of the effect comes from the 7.2 mg injection trials, where it was most frequent. There, when the prescriber paused treatment or lowered the dose, most people recovered, and the events resolved faster than when nothing was changed. Some people whose sensation did not go away during the trial had kept the same dose. That is the injection, not the pill, and it is a decision taken with the prescriber, never alone.
The Medication Guide's general rule applies:
From the labelTalk to your healthcare provider about any side effect that bothers you or does not go away.
Oolite's journal keeps side effects with their date and the dose you were on, so a sensation that started after a step up shows as such in the report for your prescriber.
Questions people ask
What does it feel like?
The label groups several sensations under one word, dysesthesia: paresthesia (tingling, pins and needles), pain of the skin, sensitive skin and a burning skin sensation. The Medication Guide calls them changes in skin sensations.
How common is it on the pill?
In the clinical trial of the 25 mg tablets, 5 percent of people on the pill reported it, and no one on placebo. The Medication Guide lists changes in skin sensations among the most common side effects.
Is it linked to the dose?
Yes. The label says the incidence of dysesthesia increased with increasing dosage and drug levels in the blood. On the pill, the top of the schedule is 25 mg.
Should I stop the pill if my skin burns?
The label does not ask you to stop on your own. The Medication Guide says to talk to your healthcare provider about any side effect that bothers you or does not go away. In the injection trials, prescribers sometimes paused treatment or lowered the dose, and most of those people recovered.
Sources
- Wegovy prescribing information, Novo Nordisk, Highlights, §2.3, §6.1 and §12.3, revised 06/2026 · Dysesthesia among the most common adverse reactions; altered skin sensations including paresthesia, pain of skin, sensitive skin and burning skin sensation, in trials with the injection and the tablet; incidence increased with dosage and blood levels; 5 percent on 25 mg tablets vs none on placebo; with 7.2 mg injection, most people whose treatment was adjusted recovered; higher variability of blood levels with the tablet (27 to 186 vs 51 to 110 nmol/L).
- Wegovy Medication Guide, Novo Nordisk, revised 06/2026 · Changes in skin sensations among the most common side effects; talk to your healthcare provider about any side effect that bothers you or does not go away.
Sources checked Oct 27, 2026. This page is information, not medical advice: read the medical disclaimer, and talk to your prescriber or pharmacist about your own treatment.
Written by
The Oolite team, from the FDA labels
We make Oolite. Every answer starts from the FDA prescribing information, quoted word for word, and is rewritten when a label changes.
How these pages are madeOolite
The GLP-1 tracker for the pill and the shot.
The 30 minute timer, your shot day, the level chart and the dose reminder, on iPhone, with Apple Watch to log. Free to download, then a 14-day free trial.
